GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | January 08, 2025 |
PDB ID | UniProt ID | Title | Descriptor |
---|---|---|---|
8AWU | P24300 | Millisecond cryo-trapping by the spitrobot crystal plunger, Xylose Isomerase with Glucose at 250ms | |
8AWV | P24300 | Millisecond cryo-trapping by the spitrobot crystal plunger, Xylose Isomerase with Glucose at 500ms | |
8AWX | P24300 | Millisecond cryo-trapping by the spitrobot crystal plunger, Xylose Isomerase with Glucose at 1s | |
8CWI | P0DTC2 | Fab arm of antibody 10G4 bound to CoV-2 receptor binding domain (RBD) | |
8CWI | 8CWI | Fab arm of antibody 10G4 bound to CoV-2 receptor binding domain (RBD) | |
8CWJ | 8CWJ | Fab arms of antibodies 4C12-B12 and CR3022 bound to pangolin receptor binding domain (pRBD) | |
8CWJ | A0A7D6TQ96 | Fab arms of antibodies 4C12-B12 and CR3022 bound to pangolin receptor binding domain (pRBD) | |
8CWK | 8CWK | Fab arm of antibodies 4G1-C2 and 10G4 bound to CoV-2 receptor binding domain (RBD) | |
8CWK | Q6GMX0 | Fab arm of antibodies 4G1-C2 and 10G4 bound to CoV-2 receptor binding domain (RBD) | |
8CWK | P0DTC2 | Fab arm of antibodies 4G1-C2 and 10G4 bound to CoV-2 receptor binding domain (RBD) | |
8D0O | Q9Y231 | Human alpha1,3-fucosyltransferase FUT9, heavy atom derivative | |
8D0P | Q9Y231 | Human FUT9, unliganded | |
8D0R | Q9Y231 | Human FUT9 bound to GDP and H-Type 2 | |
8D0S | Q9Y231 | Human FUT9 bound to GDP and LNnT | |
8D0U | Q9Y231 | Human FUT9 bound to GDP | |
8D0W | Q9Y231 | Human FUT9 bound to H-Type 2 | |
8D0X | Q9Y231 | Human FUT9 bound to LNnT | |
8DL1 | A7M087 | BoGH13ASus-E523Q from Bacteroides ovatus bound to maltoheptaose | |
8DL2 | A7M087 | BoGH13ASus from Bacteroides ovatus bound to acarbose | |
8DNN | P0DTC2 | Crystal structure of neutralizing antibody 80 in complex with SARS-CoV-2 receptor binding domain | |
8DNN | 8DNN | Crystal structure of neutralizing antibody 80 in complex with SARS-CoV-2 receptor binding domain | |
8EOG | P54286 | Structure of the human L-type voltage-gated calcium channel Cav1.2 complexed with L-leucine | |
8EOG | P13806 | Structure of the human L-type voltage-gated calcium channel Cav1.2 complexed with L-leucine | |
8EOG | Q13936-20 | Structure of the human L-type voltage-gated calcium channel Cav1.2 complexed with L-leucine | |
8EOI | Q8N766 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
8EOI | Q15006 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
8EOI | Q9P0I2 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
8EOI | Q5J8M3 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
8EOI | Q8N4V1 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
8EOI | Q9BV81 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
8EOI | Q9NPA0 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
8EOI | O43402 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
8EOI | Q5UCC4 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
8EOI | P54286 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
8EOI | Q13936 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
8F60 | 8F60 | anti-BTLA monoclonal antibody r23C8 in complex with BTLA | |
8F60 | Q7Z6A9 | anti-BTLA monoclonal antibody r23C8 in complex with BTLA | |
8G6I | P00451 | Coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor | |
8G6I | P12263 | Coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor | |
8G6I | 8G6I | Coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor | |
8GB5 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 25F9 | |
8GB5 | 8GB5 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 25F9 | |
8GB6 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 21B6 | |
8GB6 | 8GB6 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 21B6 | |
8GB7 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 20A7 | |
8GB7 | 8GB7 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 20A7 | |
8GB8 | P0DTC2 | Crystal structure of SARS-CoV-2 BA.2 receptor binding domain in complex with neutralizing antibody 20A7 | |
8GB8 | 8GB8 | Crystal structure of SARS-CoV-2 BA.2 receptor binding domain in complex with neutralizing antibody 20A7 | |
8GFM | A0A3I4HTM2 | Crystal structure of soluble lytic transglycosylase Cj0843 of Campylobacter jejuni in complex with zanamivir amine inhibitor | |
8GFP | A0A3I4HTM2 | Crystal structure of soluble lytic transglycosylase Cj0843 of Campylobacter jejuni in complex with N-acetyl-2,3-dehydro-2-deoxyneuraminic acid inhibitor |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024